Skip to main navigation Skip to search Skip to main content

The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD

  • Sayan Ghosh
  • , Ruchi Sharma
  • , Sridhar Bammidi
  • , Victoria Koontz
  • , Mihir Nemani
  • , Meysam Yazdankhah
  • , Katarzyna M. Kedziora
  • , Donna Beer Stolz
  • , Callen T. Wallace
  • , Cheng Yu-Wei
  • , Jonathan Franks
  • , Devika Bose
  • , Peng Shang
  • , Helena M. Ambrosino
  • , James R. Dutton
  • , Zhaohui Geng
  • , Jair Montford
  • , Jiwon Ryu
  • , Dhivyaa Rajasundaram
  • , Stacey Hose
    • José Alain Sahel, Rosa Puertollano, Toren Finkel, J. Samuel Zigler, Yuri Sergeev, Simon C. Watkins, Eric S. Goetzman, Deborah A. Ferrington, Miguel Flores-Bellver, Kai Kaarniranta, Akrit Sodhi, Kapil Bharti, James T. Handa, Debasish Sinha

Research output: Contribution to journal › Article › peer-review

25   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology